| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697589 | Cancer Treatment Reviews | 2017 | 50 Pages |
Abstract
Overall, high pretreatment blood NLR could be an adverse prognostic indicator for advanced tumor. Large-scale prospective studies investigating its survival outcomes in specific cancer type are strongly advocated.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Zubing Mei, Lu Shi, Bo Wang, Jizhen Yang, Zhihong Xiao, Peixin Du, Qingming Wang, Wei Yang,